ERBB2 and neoplasm: These results indicated that miR-HER2-E1 delivered by exosomes can interfere HER2 expression (Additional file 1: Fig. S3) and specifically inhibit HER2-positive tumor growth in vivo, which were consistent with the results obtained in cell culture studies.